Limerston Capital‑backed Concept Life Sciences Acquires Charnwood Discovery
November 8, 2024
Limerston Capital‑backed Concept Life Sciences (CLS) has acquired Charnwood Discovery, a UK-based drug discovery contract research provider headquartered in Loughborough. The add-on strengthens CLS's integrated drug discovery, chemistry, biology and ADME/DMPK capabilities and expands its ability to accelerate drug candidates to clinic while providing customers access to CLS's broader translational biology and GMP manufacturing services.
- Buyers
- Concept Life Sciences, Limerston Capital
- Targets
- Charnwood Discovery
- Platforms
- Concept Life Sciences
- Industry
- Healthcare Services
- Location
- Leicestershire, United Kingdom
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Limerston Capital Acquires Concept Life Sciences from Spectris plc
April 3, 2023
Biotechnology
Limerston Capital LLP has acquired Concept Life Sciences, a UK-based contract research organisation (CRO), in a carve-out from Spectris plc through its new fund Limerston Capital Partners II. The deal provides Concept Life Sciences with independent ownership, new leadership under CEO Dr Ben Cliff and additional investment to support growth across its drug discovery, development and API manufacturing services. Limerston intends to use the business as a platform for further buy-and-build and operational expansion in the life sciences sector.
-
Synova Capital Invests in Charnwood Molecular
January 1, 2020
Biotechnology
Synova Capital has completed a significant growth investment into Charnwood Molecular to support the company's next phase of expansion. The funding will be used to accelerate Charnwood’s development of higher‑value chemistry, broaden its scientific service offering, and pursue selective acquisitions to expand capabilities and address strong demand from pharma and biotech clients.
-
Limerston Capital Acquires CyberCrowd to Build Cybersecurity Platform
May 27, 2024
Cybersecurity
London-based private equity firm Limerston Capital has acquired UK-based cyber security services specialist CyberCrowd as the first step in building a new cybersecurity platform alongside assets from an earlier acquisition. The combined group will offer digital forensics, e-Discovery, a proprietary forensic case management tool, a 24/7 UK-based SOC, incident response, and scaled consultancy and penetration testing services to public and private sector clients.
-
Lumanity Acquires Clarion Healthcare from Svoboda Capital Partners
November 8, 2022
Healthcare Services
Lumanity, a portfolio company of Arsenal Capital Partners, has acquired Boston-based life sciences consultancy Clarion Healthcare from Svoboda Capital Partners. The undisclosed transaction expands Lumanity’s U.S. commercialization and product lifecycle consulting capabilities and creates greater global scale for life sciences strategy services.
-
Calibre Scientific Acquires Canadian Life Science
December 14, 2020
Healthcare Services
Calibre Scientific, a global provider of life-science reagents and consumables, has acquired Canadian Life Science (CLS), a Peterborough, Ontario-based distributor of chromatography and laboratory consumables. The acquisition gives Calibre an established distribution hub in Canada and expands its North American footprint to support co-sales and broader customer interactions.
-
Trinity Homecare (Limerston Capital portfolio) Acquires Berkeley Home Health Limited
September 22, 2021
Healthcare Services
Limerston Capital’s portfolio company Trinity Homecare Group Limited has acquired Berkeley Home Health Limited, a southeast England domiciliary care provider operating three brands and ten regional branches. The add-on expands Trinity’s footprint and creates a nationwide private-pay homecare platform in the United Kingdom.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.